Search - tctmd.com

Displaying 21 - 40 of 126

Sort: Relevancy | Date

Presentation TCT 2017

First of the Class: Tissue Engineering

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Andreu M Climent

October 31, 2017

Presentation TCT 2017

New Strategies for a Chronic Scenario: Combinative Approaches

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Amit N. Patel

October 31, 2017

Presentation TCT 2017

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

New Targets: Heart Failure With Preserved Ejection Fraction

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

In Which Direction is Cell Based Heart Failure Therapy Headed?

Presenter: Francisco Fdez-Aviles, Emerson C. Perin

October 31, 2017

Presentation TCT 2017

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz

October 31, 2017

Presentation TCT 2017

US Trial Background and Update: Preserve-AMI

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Jose M. de la Torre Hernandez

October 31, 2017

Presentation TCT 2017

TCT 75: Impact of the Timing of P2Y12 Inhibitor Discontinuation Prior to CABG in Patients With Left Main Disease: Results from the EXCEL Trial

Presenter: Adrian P. Banning, John D. Puskas, Christopher Kelly, MD

October 31, 2017

Presentation TCT 2017

The Global Vision of Cardiovascular Regenerative Medicine: The TACTICS Alliance

Presenter: Anthony N. DeMaria, Francisco Fdez-Aviles

October 30, 2017

Presentation TCT 2017

In This Case: Doppler-Based CFR Uncovered Discordance With FFR (With Discussion)

Presenter: Justin E. Davies, Nils Johnson, Tim P. van de Hoef

October 30, 2017

Presentation TCT 2017

The American Vision of Regenerative Cardiovascular Medicine

Presenter: Anthony N. DeMaria, Francisco Fdez-Aviles

October 30, 2017

Presentation TCT 2017

The European Vision of Regenerative Cardiovascular Medicine: The New CARE Working Group of the ESC

Presenter: Anthony N. DeMaria, Francisco Fdez-Aviles, Jens Kastrup

October 30, 2017

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

News Daily News

Perfect Timing? Afternoon Valve Surgeries Have Fewer Complications

Michael O'Riordan

October 27, 2017

News Daily News

Preventing Dementia May Be Another Reason to Take Oral Anticoagulants for A-fib

Todd Neale

October 25, 2017

News Daily News

Lesion Complexity and Patient Risk: A Balancing Act for DAPT Duration

Yael L. Maxwell

October 23, 2017

News Daily News

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Michael O'Riordan

October 19, 2017

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

Advertisement

First of the Class: Tissue Engineering

New Strategies for a Chronic Scenario: Combinative Approaches

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

New Targets: Heart Failure With Preserved Ejection Fraction

In Which Direction is Cell Based Heart Failure Therapy Headed?

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

US Trial Background and Update: Preserve-AMI

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

TCT 75: Impact of the Timing of P2Y12 Inhibitor Discontinuation Prior to CABG in Patients With Left Main Disease: Results from the EXCEL Trial

The Global Vision of Cardiovascular Regenerative Medicine: The TACTICS Alliance

In This Case: Doppler-Based CFR Uncovered Discordance With FFR (With Discussion)

The American Vision of Regenerative Cardiovascular Medicine

The European Vision of Regenerative Cardiovascular Medicine: The New CARE Working Group of the ESC

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Perfect Timing? Afternoon Valve Surgeries Have Fewer Complications

Preventing Dementia May Be Another Reason to Take Oral Anticoagulants for A-fib

Lesion Complexity and Patient Risk: A Balancing Act for DAPT Duration

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content